{"count": 75, "results": [{"_id": "36187122", "pmid": 36187122, "pmcid": "PMC9524196", "title": "Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials", "journal": "Front Endocrinol (Lausanne)", "authors": ["Nabrdalik K", "Skonieczna-Żydecka K", "Irlik K", "Hendel M", "Kwiendacz H", "Łoniewski I", "Januszkiewicz K", "Gumprecht J", "Lip GYH"], "date": "2022-09-14T00:00:00Z", "doi": "10.3389/fendo.2022.975912", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "975912", "score": 50278.355, "text_hl": "The effect size (RR) for @<m>DISEASE_Nausea</m> @DISEASE_MESH:D009325 @@@nausea@@@ in @SPECIES_9606 @@@patients@@@ taking @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (intervention) vs. comparator (control).", "citations": {"NLM": "Nabrdalik K, Skonieczna-Żydecka K, Irlik K, Hendel M, Kwiendacz H, Łoniewski I, Januszkiewicz K, Gumprecht J, Lip GYH. Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials Front Endocrinol (Lausanne). 2022;13():975912. PMID: 36187122", "BibTeX": "@article{36187122, title={Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials}, author={Nabrdalik K and Skonieczna-Żydecka K and Irlik K and Hendel M and Kwiendacz H and Łoniewski I and Januszkiewicz K and Gumprecht J and Lip GYH}, journal={Front Endocrinol (Lausanne)}, volume={13}, pages={975912}}"}}, {"_id": "36077758", "pmid": 36077758, "pmcid": "PMC9454846", "title": "Metformin with Temozolomide for Newly Diagnosed Glioblastoma: Results of Phase I Study and a Brief Review of Relevant Studies", "journal": "Cancers (Basel)", "authors": ["Ohno M", "Kitanaka C", "Miyakita Y", "Tanaka S", "Sonoda Y", "Mishima K", "Ishikawa E", "Takahashi M", "Yanagisawa S", "Ohashi K", "Nagane M", "Narita Y"], "date": "2022-08-30T00:00:00Z", "doi": "10.3390/cancers14174222", "meta_date_publication": "2022 Aug 30", "meta_volume": "14", "meta_issue": "17", "meta_pages": "", "score": 50272.39, "text_hl": "They evaluated six @SPECIES_9606 @@@patients@@@ with newly diagnosed and seven with recurrent high-grade @DISEASE_Glioma @DISEASE_MESH:D005910 @@@gliomas@@@, and concluded that 1700 mg/day @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MF@@@ (850 mg twice a day) was acceptable, but 2550 mg/day @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MF@@@ (850 mg three times a day) was poorly tolerated due to @<m>DISEASE_Nausea</m> @DISEASE_MESH:D009325 @@@nausea@@@. ", "citations": {"NLM": "Ohno M, Kitanaka C, Miyakita Y, Tanaka S, Sonoda Y, Mishima K, Ishikawa E, Takahashi M, Yanagisawa S, Ohashi K, Nagane M, Narita Y. Metformin with Temozolomide for Newly Diagnosed Glioblastoma: Results of Phase I Study and a Brief Review of Relevant Studies Cancers (Basel). 2022 Aug 30;14(17):. PMID: 36077758", "BibTeX": "@article{36077758, title={Metformin with Temozolomide for Newly Diagnosed Glioblastoma: Results of Phase I Study and a Brief Review of Relevant Studies}, author={Ohno M and Kitanaka C and Miyakita Y and Tanaka S and Sonoda Y and Mishima K and Ishikawa E and Takahashi M and Yanagisawa S and Ohashi K and Nagane M and Narita Y}, journal={Cancers (Basel)}, volume={14}, number={17}}"}}, {"_id": "37816179", "pmid": 37816179, "title": "Compounding Metformin for Use in Functional Medicine.", "journal": "Int J Pharm Compd", "authors": ["Desai S", "Thompson T"], "date": "2023-09-01T00:00:00Z", "meta_date_publication": "2023 Sep-Oct", "meta_volume": "27", "meta_issue": "5", "meta_pages": "362-366", "score": 50260.02, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ can cause issues with the gastrointestinal tract and result in @<m>DISEASE_Nausea</m> @DISEASE_MESH:D009325 @@@nausea@@@, @DISEASE_Abdominal_Pain @DISEASE_MESH:D015746 @@@abdominal pain@@@, @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhea@@@, @DISEASE_Gas_bloat_syndrome @DISEASE_MESH:C535647 @@@bloating@@@, or @DISEASE_Vomiting @DISEASE_MESH:D014839 @@@vomiting@@@. ", "citations": {"NLM": "Desai S, Thompson T. Compounding Metformin for Use in Functional Medicine. Int J Pharm Compd. 2023 Sep-Oct;27(5):362-366. PMID: 37816179", "BibTeX": "@article{37816179, title={Compounding Metformin for Use in Functional Medicine.}, author={Desai S and Thompson T}, journal={Int J Pharm Compd}, volume={27}, number={5}, pages={362-366}}"}}, {"_id": "35602825", "pmid": 35602825, "pmcid": "PMC9117863", "title": "Metformin-Associated Lactic Acidosis: A Case Report and Review", "journal": "Cureus", "authors": ["Ashraf S", "Upreti P", "Karki S", "Khan M", "Nasr R"], "date": "2022-04-17T00:00:00Z", "doi": "10.7759/cureus.24220", "meta_date_publication": "2022 Apr", "meta_volume": "14", "meta_issue": "4", "meta_pages": "e24220", "score": 50258.875, "text_hl": "While the @DISEASE_Gastrointestinal_Diseases @DISEASE_MESH:D005767 @@@gastrointestinal@@@ side effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ such as @<m>DISEASE_Nausea</m> @DISEASE_MESH:D009325 @@@nausea@@@, @DISEASE_Vomiting @DISEASE_MESH:D014839 @@@vomiting@@@, @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhea@@@, and @DISEASE_Heartburn @DISEASE_MESH:D006356 @@@heartburn@@@ are quite common, one dangerous side effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@lactic acidosis@@@, is extensively discussed yet rarely reported. ", "citations": {"NLM": "Ashraf S, Upreti P, Karki S, Khan M, Nasr R. Metformin-Associated Lactic Acidosis: A Case Report and Review Cureus. 2022 Apr;14(4):e24220. PMID: 35602825", "BibTeX": "@article{35602825, title={Metformin-Associated Lactic Acidosis: A Case Report and Review}, author={Ashraf S and Upreti P and Karki S and Khan M and Nasr R}, journal={Cureus}, volume={14}, number={4}, pages={e24220}}"}}, {"_id": "36384864", "pmid": 36384864, "pmcid": "PMC9679981", "title": "Unusual Case of Metformin-Associated Lactic Acidosis in Patient with Type 2 Diabetes Mellitus", "journal": "Am J Case Rep", "authors": ["Hai PD", "Thu NT", "Phuong LL", "Manh NV", "Hoa LTV"], "date": "2022-11-17T00:00:00Z", "doi": "10.12659/AJCR.937865", "meta_date_publication": "2022 Nov 17", "meta_volume": "23", "meta_issue": "", "meta_pages": "e937865", "score": 50257.05, "text_hl": "Nevertheless, the intentional increase of his dose of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ to 3000 mg per day led to @DISEASE_Gastrointestinal_Diseases @DISEASE_MESH:D005767 @@@gastrointestinal reactions@@@, including @<m>DISEASE_Nausea</m> @DISEASE_MESH:D009325 @@@nausea@@@, @DISEASE_Vomiting @DISEASE_MESH:D014839 @@@vomiting@@@, @DISEASE_Abdominal_Pain @DISEASE_MESH:D015746 @@@abdominal pain@@@, and @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhea@@@, which caused severe @DISEASE_Dehydration @DISEASE_MESH:D003681 @@@dehydration@@@, followed by the development of @DISEASE_Acute_Kidney_Injury @DISEASE_MESH:D058186 @@@acute kidney injury@@@, one of the results of @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@MALA@@@.", "citations": {"NLM": "Hai PD, Thu NT, Phuong LL, Manh NV, Hoa LTV. Unusual Case of Metformin-Associated Lactic Acidosis in Patient with Type 2 Diabetes Mellitus Am J Case Rep. 2022 Nov 17;23():e937865. PMID: 36384864", "BibTeX": "@article{36384864, title={Unusual Case of Metformin-Associated Lactic Acidosis in Patient with Type 2 Diabetes Mellitus}, author={Hai PD and Thu NT and Phuong LL and Manh NV and Hoa LTV}, journal={Am J Case Rep}, volume={23}, pages={e937865}}"}}, {"_id": "32733769", "pmid": 32733769, "pmcid": "PMC7384516", "title": "A Rare Case of Metformin Intoxication with Mortal Course", "journal": "Medeni Med J", "authors": ["Osoydan Satici M", "Algin A", "Aksel G", "Eroglu SE"], "date": "2020-01-01T00:00:00Z", "doi": "10.5222/MMJ.2020.96641", "meta_date_publication": "2020", "meta_volume": "35", "meta_issue": "2", "meta_pages": "175-178", "score": 50256.93, "text_hl": "A 33 year-old female @SPECIES_9606 @@@patient@@@ was admitted to the emergency department, with @<m>DISEASE_Nausea</m> @DISEASE_MESH:D009325 @@@nausea@@@ and @DISEASE_Vomiting @DISEASE_MESH:D014839 @@@vomiting@@@ after taking 30 tablets of 1000 mg @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Osoydan Satici M, Algin A, Aksel G, Eroglu SE. A Rare Case of Metformin Intoxication with Mortal Course Medeni Med J. 2020;35(2):175-178. PMID: 32733769", "BibTeX": "@article{32733769, title={A Rare Case of Metformin Intoxication with Mortal Course}, author={Osoydan Satici M and Algin A and Aksel G and Eroglu SE}, journal={Medeni Med J}, volume={35}, number={2}, pages={175-178}}"}}, {"_id": "32850203", "pmid": 32850203, "pmcid": "PMC7444850", "title": "A Case Report on Metformin-Associated Lactic Acidosis and Transient Blindness", "journal": "Cureus", "authors": ["Kalantri P", "Sahu A", "Kalantri A"], "date": "2020-07-21T00:00:00Z", "doi": "10.7759/cureus.9325", "meta_date_publication": "2020 Jul 21", "meta_volume": "12", "meta_issue": "7", "meta_pages": "e9325", "score": 50253.145, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ mostly causes @DISEASE_Drug_Related_Side_Effects_and_Adverse_Reactions @DISEASE_MESH:D064420 @@@gastrointestinal side effects@@@, including @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhea@@@, @DISEASE_Flatulence @DISEASE_MESH:D005414 @@@flatulence@@@, @<m>DISEASE_Nausea</m> @DISEASE_MESH:D009325 @@@nausea@@@, @DISEASE_Vomiting @DISEASE_MESH:D014839 @@@vomiting@@@, and @DISEASE_Infections @DISEASE_MESH:D007239 @@@infections@@@. ", "citations": {"NLM": "Kalantri P, Sahu A, Kalantri A. A Case Report on Metformin-Associated Lactic Acidosis and Transient Blindness Cureus. 2020 Jul 21;12(7):e9325. PMID: 32850203", "BibTeX": "@article{32850203, title={A Case Report on Metformin-Associated Lactic Acidosis and Transient Blindness}, author={Kalantri P and Sahu A and Kalantri A}, journal={Cureus}, volume={12}, number={7}, pages={e9325}}"}}, {"_id": "37260725", "pmid": 37260725, "pmcid": "PMC10228116", "title": "Severe metabolic acidosis due to massive metformin overdose in a man: a case report", "journal": "Oxf Med Case Reports", "authors": ["Manouchehri A", "Rashidian H", "Zakariaei Z"], "date": "2023-05-30T00:00:00Z", "doi": "10.1093/omcr/omad049", "meta_date_publication": "2023 May", "meta_volume": "2023", "meta_issue": "5", "meta_pages": "omad049", "score": 50251.355, "text_hl": "Following a suicide attempt with an @DISEASE_Drug_Overdose @DISEASE_MESH:D062787 @@@overdose@@@ of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, he experienced symptoms such as @<m>DISEASE_Nausea</m> @DISEASE_MESH:D009325 @@@nausea@@@, @DISEASE_Vomiting @DISEASE_MESH:D014839 @@@vomiting@@@, @DISEASE_Muscle_Weakness @DISEASE_MESH:D018908 @@@weakness@@@ and @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@lactic acidosis@@@. ", "citations": {"NLM": "Manouchehri A, Rashidian H, Zakariaei Z. Severe metabolic acidosis due to massive metformin overdose in a man: a case report Oxf Med Case Reports. 2023 May;2023(5):omad049. PMID: 37260725", "BibTeX": "@article{37260725, title={Severe metabolic acidosis due to massive metformin overdose in a man: a case report}, author={Manouchehri A and Rashidian H and Zakariaei Z}, journal={Oxf Med Case Reports}, volume={2023}, number={5}, pages={omad049}}"}}, {"_id": "39256177", "pmid": 39256177, "title": "Metformin-associated lactic acidosis: a serious complication of a common drug.", "journal": "BMJ Case Rep", "authors": ["Malani KA", "Finn A"], "date": "2024-09-10T00:00:00Z", "doi": "10.1136/bcr-2024-260592", "meta_date_publication": "2024 Sep 10", "meta_volume": "17", "meta_issue": "9", "meta_pages": "", "score": 50250.598, "text_hl": "We report a case of @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@MALA@@@ in a man in his 70s with @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ who presented with gradually worsening @DISEASE_Signs_and_Symptoms_Digestive @DISEASE_MESH:D012817 @@@gastrointestinal symptoms@@@, including severe @DISEASE_Abdominal_Pain @DISEASE_MESH:D015746 @@@abdominal pain@@@ and @<m>DISEASE_Nausea</m> @DISEASE_MESH:D009325 @@@nausea@@@. He reported these symptoms in the setting of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use with an @DISEASE_Acute_Kidney_Injury @DISEASE_MESH:D058186 @@@acute kidney injury@@@ (@DISEASE_Acute_Kidney_Injury @DISEASE_MESH:D058186 @@@AKI@@@), likely brought on by poor oral intake and excessive antibiotic use for a @DISEASE_Urinary_Tract_Infections @DISEASE_MESH:D014552 @@@urinary tract infection@@@. ", "citations": {"NLM": "Malani KA, Finn A. Metformin-associated lactic acidosis: a serious complication of a common drug. BMJ Case Rep. 2024 Sep 10;17(9):. PMID: 39256177", "BibTeX": "@article{39256177, title={Metformin-associated lactic acidosis: a serious complication of a common drug.}, author={Malani KA and Finn A}, journal={BMJ Case Rep}, volume={17}, number={9}}"}}, {"_id": "37450235", "pmid": 37450235, "title": "Fabrication and characterization of coated microneedle patches based on PEGDA for transdermal administration of metformin.", "journal": "Drug Deliv Transl Res", "authors": ["Zhou B", "Guo Z", "Zhao P", "Wang H", "Dong S", "Cheng B", "Yang J", "Li B", "Wang X"], "date": "2023-07-14T00:00:00Z", "doi": "10.1007/s13346-023-01387-8", "meta_date_publication": "2023 Jul 14", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50247.117, "text_hl": "@DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@Type 2 diabetes@@@ is one of the major challenges that the world is facing today. However, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@) as most @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetics@@@' first-line oral hypoglycemic drug may cause serious side effects such as @DISEASE_Gastrointestinal_Diseases @DISEASE_MESH:D005767 @@@gastrointestinal irritation@@@ and @<m>DISEASE_Nausea</m> @DISEASE_MESH:D009325 @@@nausea@@@ which reduce the patients' medication compliance. ", "citations": {"NLM": "Zhou B, Guo Z, Zhao P, Wang H, Dong S, Cheng B, Yang J, Li B, Wang X. Fabrication and characterization of coated microneedle patches based on PEGDA for transdermal administration of metformin. Drug Deliv Transl Res. 2023 Jul 14;():. PMID: 37450235", "BibTeX": "@article{37450235, title={Fabrication and characterization of coated microneedle patches based on PEGDA for transdermal administration of metformin.}, author={Zhou B and Guo Z and Zhao P and Wang H and Dong S and Cheng B and Yang J and Li B and Wang X}, journal={Drug Deliv Transl Res}}"}}]}